Designation: Assistant Professor Faculty / Institute / Centre : Faculty of Accountancy and Management Department / Unit: Department of Economics Telephone No: +603-90860288 ext Fax: +603-90197062 Email Address: yogambigai@utar.edu.my Scopus Profile : https://www.scopus.com/authid/detail.uri?authorId=57189632631 Google Scholar Profile : https://scholar.google.com/citations?hl=en&user=eDIvDJoAAAAJ Orcid ID : https://orcid.org/0000-0002-3222-4346
Qualification:	Doctor of Philosophy, Universiti Putra Malaysia ( Economics ) Master of Economics, Universiti Putra Malaysia Bachelor of Economics (Hons), Universiti Malaya

Dr Yogambigai Rajamoorthy is an Assistant Professor at Faculty of Accountancy and Management at Universiti Tunku Abdul Rahman (UTAR), Malaysia. She holds a Doctorate of Philosophy and Master degree in Economics from Universiti Putra Malaysia and bachelor degree in Economics from University of Malaya. In addition, she also teaching the undergraduate programmes related to Economics & Health Economics at UTAR. Her area of expertise/research interest including Health Economics and Applied Economics. She also authored, co-authored and reviewed several scholarly works in the domain of economic valuation specifically in willingness to pay. She has also served as lead consultant and co-researcher for several public funded projects in consultancy including Malaysia (Universiti Putra Malaysia & UTAR), Taiwan (Ministry of Education) and United States of America (National Science Foundation). She is also a member of American Economic Association and International Health Economics Association. Over the years, she has devoted most of her energy and time to research the economic valuation of marketable vaccines for the effectiveness of public health policy.   As an economist and social science researcher, she strongly believes that public health policy should reflect an understanding of the public’s values. Because of public values such as willingness to pay and perception of newly discovered vaccines often not generally expressed in the marketplace. Understanding the cost-effectiveness of vaccine-preventable diseases and consumer preferences on vaccines are vital in decision making and future intervention of vaccines. She truly inspired to investigate the economic valuation of consumer willingness to pay for several other new and existing vaccines for infectious diseases that will serve as a guideline for important stakeholders.